Written by Andrea Fields MHA, RDCS

Essential Steps to Evaluating MR Etiologies

The ASE recently released their new 2017 valvular regurgitation updated guidelines back in April. The paper details the difference between primary and secondary mitral regurgitation (MR) and outlines proper evaluation methods for the most common pathologies seen.  The past couple of weeks, we have discussed how to differentiate between primary vs. organic and acute vs. chronic. If you need to refresh or missed our blog, you can read them here:

  1. Mitral Valve Anatomy: Name 5 Components! 
  2. Finally… Mitral Valve Orientation Explained!
  3. Smart Strategies for Determining MR Mechanisms
  4. Ultimate Guide to Acute vs. Chronic MR

This week the goal for our blog is to provide a clear & easy breakdown on how to evaluate different abnormalities of the mitral valve.  We will review the Carpentier classification and how it relates to evaluation of the following abnormalities of the mitral valve:

  1. Myxomatous Degeneration (Prolapse & Flail)
  2. Barlow’s Disease

Carpentier Classification

Dr. Alain Carpentier is a french surgeon who developed the pathophysiological triad and Carpentier classification method for evaluation of mitral valve disease. This criteria chart is helpful for functional classification of mitral valve disease and is used by cardiologist and surgeons to aid with decision making on repair vs. replacement of the mitral valve.

Etiology is relevant to long-term prognosis, therefore placed at the top of the triangle. The bottom two corners (lesions and dysfunction) are relevant for treatment strategy.

pathophysiological triad

Examples include:

  • Etiology = Fibroelastic deficiency vs. Barlow’s disease
  • Lesions:  Chordal elongation or rupture; leaflet distention; annular dilatation; leaflet or papillary muscle calcification
  • Dysfunction:  Defined according to systolic position and motion of leaflet margins in relation to annular plane

Let’s review Dr. Carpentier functional classification chart to describe the mechanism of the valve dysfunction, based upon opening & closing motions of leaflets.

carpentier's functional classification

Primary/Organic MR

Degenerative MV disease is the most common cause of primary MR. The two most common types of myxomatous degenerative MV disease include: fibroelastic deficiency & Barlow’s disease.  Learn more about primary/organic MR in our recent MR mechanism blog.

Myxomatous Degeneration

5 Facts about Mitral Valve Prolapse (MVP)

Mitral Valve Prolapse (MVP) is a type of primary myxomatous valve disease. This happens when there is a fibroelastic deficiency to a focal segment of the leaflet, causing a systolic displacement of the leaflet into the left atrium (LA).

  1. 3:1 Female to Male Ratio
  2. Regurgitation can range from mild-severe
  3. Mid-to-late systolic murmur
  4. Associated with connective tissue disorders
  5. Carpentier’s Classification: Type II Dysfunction

MVP

How to Image: MVP

When evaluating the severity of MVP, it is suggested to do so in the parasternal long axis (PLAX) window. Apical 4 and 2 chamber windows are not ideal for diagnosing MVP due to the mitral annulus sitting too low, which can lead to a falsely displaced leaflets into the LA.

Measurment Tips!

  • PLAX window for measurement
  • Distance from systolic displacement to mitral annulus
  • >2mm = prolapse present

MV prolapse

4 Causes of  MV Flail Leaflet

Flail Leaflet is when the leaflet edge and body have free motion into the LA, commonly due to rupture of chordae. It is usually always associated with severe regurgitation. In extreme cases, flail MV can be caused from papillary muscle rupture. Causes of rupture chordae can be due to:

  1. Spontaneous (primary)
  2. Endocarditits
  3. Trauma
  4. Acute LV Dilatation

Mitral Valve Flail Anatomy Echo

How to Image: Flail Leaflet

  • Flail gap = from tip of fail segment to opposite normal coapting leaflet
  • To qualify for MV Repair: Flail gap < 10 mm

Mitral Valve Flail Measurement

6 Ways to Identify Barlow’s Disease

Barlow’s Disease is an extreme case of MVP, due to an excessive amount of myxomatous tissue being present. Commonly both leaflets, (including multiple segments) become thick, bulky and redundant causing leaflets to ‘billow‘. In most cases, the mitral annulus will become dilated & enlarged and the chordae will be elongated.

  1. Coaptation line is below annular plane
  2. Leaflet bodies displaced into LA
  3. Leaflet tips remain at or above annular plane (into LV)
  4. Commonly found in younger patients
  5. Chronic & asymptomatic process
  6. Carpentier’s Classification: Type II Dysfunction

Mitral Valve Billowing vs Prolapse

Summary

This week we reviewed the Carpentier Triad and discussed how to properly identify and evaluate primary mitral valve disease, including:

  • Myxomatous Degeneration (Prolapse & Flail)
  • Barlow’s Disease

As physicians, sonographers & healthcare clinicians–we need to remember the importance of identifying the mechanism & etiology that causes mitral regurgitation. They play a major role in the severity of the regurgitation, cardiac remodeling and management process of the patient. Stay tuned for the upcoming weeks to follow as we dig deeper into our mitral regurgitation blog series!

Our goal at CardioServ is to provide you with an easy process of understanding and properly evaluating mitral regurgitation! We look forward to hearing feedback and comments from our readers!

Andrea Fields MHA, RDCS

Stay Connected: LinkedIn, Facebook, Twitter, Instagram

 

 

 

 

References: 

Jouan, J. (2014). Mitral Valve Repair Over Five Decades. Annals of Cardiothoracic Surgery,4(4), 322-335. Retrieved July 6, 2017, from http://www.annalscts.com/article/view/6825/7706

Asgar, A. W., Mack, M. J., & Stone, G. W. (2015). Secondary Mitral Regurgitation in Heart Failure. Journal of the American College of Cardiology,65(12), 1231-1249. Retrieved July 6, 2017, from http://www.onlinejacc.org/content/65/12/1231?_ga=2.101757569.1871068379.1498150942-2075798501.1487771433

Saito, K., Okura, H., Watanabe, N., Obase, K., & Tamada, T. (2012). Influence of Chronic Tethering of Mitral Valve on Mitral Leaflet Size and Coaptation in Functional Mitral Regurgitation. Jour,5(4), 337-344. Retrieved July 6, 2017, from http://www.imaging.onlinejacc.org/content/5/4/337?_ga=2.169400609.1871068379.1498150942-2075798501.1487771433

Dal-Bianco, J. P., MD, Aikawa, E., MD, Bischoff, J., PhD, Guerrero, J. L., BS, & Hjortanes, J., MD. (2016). Myocardial Infarction Alters Adaptation of the Tethered Mitral Valve. Journal of the American College of Cardiology,67(3), 275-288. Retrieved July 6, 2017, from http://www.onlinejacc.org/content/67/3/275?_ga=2.126940813.1871068379.1498150942-2075798501.1487771433

Zoghbi, W. A., MD, FASE, & Adams, D., RCS, RDCS, FASE. (2017). Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation. JASE, 30, 4th ser., 1-69. Retrieved June 12, 2017.

ASE guidelinesBarlow's Diseasecardiac chamber quantificationFlail Mitral ValveFunctional MRleft atriumleft ventricleMitral ApparatusMitral Leafletsmitral regurgitationnMitral TetheringMitral ValveMitral Valve ProlapseMVPOrganic MRpapillary musclesPrimary MRSecondary MR

LET US KNOW WHAT YOU THINK...

eduardo garces
Nice and didactic presentation. Thanks
Tadesse Gemechuhow d
excellent!

Your email will not be displayed.

Required *

 

Blog
Sign Up

Accreditation
services

Full Service Accreditation
Online
CME
Accreditation Software
Free
Consultation

Blog
Categories

Blog
Archive

Tags
Used

Show tags
Sign Up Share